Immunome Inc at JPMorgan Healthcare Conference Transcript
Hi, good morning. Welcome to the JPMorgan Healthcare Conference. My name is [Rajiv Gunasekar]. I'm with the Healthcare Investment Banking Team at JPM. This morning, I'm pleased to introduce the team from Immunome. We have their CEO, Clay Siegall, and the CSO, Jack Higgins. Thank you.
Thanks, Raj. I am delighted to be here and present to you on Immunome. Before I get started, I'd like to mention that I'll be making forward-looking statements. Please refer to our SEC filings for more information.
Now, I'd like to tell you a little bit about Immunome. And it's a company that was put together in a merger in October, so only a little more than three months ago. But before I begin to tell you about Immunome, I just wanted to make one word about Seagen. I founded Seagen and built it for 25 years. I am very proud of Seagen and its impact on patients, cancer patients, and was excited to build the company over time.
And
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |